Optimization of early diagnosis of ovarian cancer using an original software ScOv
https://doi.org/10.17650/1994-4098-2019-15-2-71-76
Abstract
The most common causes of treatment failure in ovarian cancer (ОС) include late diagnosis due to the absence of screening programs for its early detection and lack of vigilance by general practitioners and gynecologists. World experience suggests that screening of 100% of women has a minimal impact on mortality. Examination of women at high risk for OC is a sensible alternative to mass screening. This examination can be performed using universal computerized screening, which is a very promising and cost-effective method.
To identify the symptoms significantly associated with early-stage OC, we questionnaired 100 patients with morphologically verified stage IA–IC OC, admitted to the Department of Gynecology, Tula Regional Oncology Dispensary between 2010 and 2017 (experimental group). The control group included 200 women without malignant diseases, who underwent preventive medical examination in outpatient units of Tula. We analyzed the significance of 22 clinical symptoms and developed original computer software ScOv, which was subsequently used for identifying patients at high risk of OC among women aged 40 years and older by evaluating their complaints. The sensitivity and specificity of ScOv were 73.7 % and 88.8 % respectively. A retrospective check of the developed program demonstrated its high efficiency and prognostic value.
About the Authors
S. V. KhabarovRussian Federation
Department of Obstetrics and Gynecology, Medical Institute; 128 Boldina St., Tula 300012;
Department of Clinical Laboratory Diagnostics and Pathological Anatomy; 91 Volokolamskoe Shosse, Moscow 125371
S. O. Nikogosyan
Russian Federation
Department of Obstetrics and Gynecology
23 Kashirskoe Shosse, Moscow 115478
V. G. Volkov
Russian Federation
Department of Obstetrics and Gynecology, Medical Institute
128 Boldina St., Tula 300012
G. M. Chibisova
Russian Federation
Department of Obstetrics and Gynecology, Medical Institute
128 Boldina St., Tula 300012
References
1. Venediktova M.G., Dobrokhotova Yu.Eh. Cancers in the practice of the gynecologist. Moscow: GEOTАR-Media, 2015. 288 p. (In Russ.)
2. Аksel’ E.M. Morbidity and mortality from malignant neoplasms of the female reproductive system in Russia. Onkoginekologiya = Gynecologic Oncology 2015;(1):6–15. (In Russ.)
3. Kaprin А.D., Starinskij V.V., Petrova G.V. The state of cancer care in Russia in 2017. Moscow: Rossijskij Tsentr informatsionnykh tekhnologij i ehpidemiologicheskikh issledovanij v oblasti onkologii v sostave FGBU «MNIOI im. P.А. Gertsena» (filial FGBU «Natsionalnyj meditsinskij issledovatelskij tsentr radiologii» Minzdrava Rossii), 2018. (In Russ.)
4. Urmancheeva А.F., Kutusheva G.F., Ulrikh E.А. Ovarian carcinoma (clinical features, diagnosis and treatment). Saint Petersburg: LLC «Izdatel’stvo N-L», 2008. 68 p. (In Russ.)
5. Nikogosyan S.O., Kuznetsov V.V., Zagashtokov А.Z. Early detection of ovarian cancer: overcoming difficulties. Status Praesens 2017;3(39):29–36. (In Russ.)
6. Zhordania K.I., Kalinicheva E.V. New paradigm in the etiology of serous ovarian cancer. Rossijskij bioterapevticheskij zhurnal = Russian Biotherapeutic Journal 2014;(2):95–102. (In Russ.)
7. Kira E.F., Sinchikhin S.P., Stepanyan L.V., Mamiev O.B. The main issues of oncogynecology. Moscow: GEOTАR-Media, 2018. 288 p. (In Russ.)
8. Makarov O.V., Moshkovskij S.А., Karpova M.А., Narimanova M.R. Current state of the problem of early diagnosis of ovarian cancer and ways to solve it (literature review). Opukholi zhenskoj reproduktivnoj sistemy = Tumors of female reproductive system 2015;11(1): 76–82. (In Russ.)
9. Gerfanova E.V., Ashrafyan L.A., Antonova I.B. et al. Screening for ovarian cancer: reality and prospects. Review of the literature. Opu kholi zhenskoj reproduktivnoj sistemy = Tumors of female reproductive system 2015;11(1):69–75. (In Russ.)
10. Hamilton W., Peters T.J., Bankhead C., Sharp D. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009;339:b2998.
11. Jacobs I.J., Menon U., Ryan A. et al. Ovarian cancer screening and mortality in the UK Collborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial. Lancet 2016;387(10022):945–56.
12. Rogovskaya S.I., Ovsyannikova T.V., Lishhuk O.V. I’m going to look for... The organization of cancer screening of the female reproductive system. Status Praesens 2018;5(51):39–45. (In Russ.)
13. The role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk, 2011. Available at: http://www.sgo.org/content/up-loads/2012/09/ACOG-SGO-committee.opinion.Role-of-OB-Gyn.2011.
14. Chibisova G.M., Khabarov S.V. Complex determination of oncoprotein CA-125, HE4 and ROMA index as a prognosis of ovarian cancer. Vestnik novykh meditsinskikh tekhnologij = Journal of New Medical Technologies 2018;25(3):15–20. (In Russ.)
15. Bray F., Ren J.S., Masuyer E., Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132(5):1133–45.
16. Bokhman Ya.V., Maksimov S.Ya., Bakhidze E.V. Detection of solitary and primary multiple tumors in the female reproductive system on the basis of selective screening: new medical technology. Federalnoe agentstvo po vysokotekhnologichnoj meditsinskoj pomoshhi, FGU «NII onkologii im. N.N. Petrova Rosmedtekhnologij». Saint Petersburg: LLC «Izdatel’stvo N-L», 2008. (In Russ.)
17. Sköld C., Borge T., Ekbom A. et al. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. Int J Cancer 2018;143(8):1858–67. DOI: 10.1002/ijc.31581.
Review
For citations:
Khabarov S.V., Nikogosyan S.O., Volkov V.G., Chibisova G.M. Optimization of early diagnosis of ovarian cancer using an original software ScOv. Tumors of female reproductive system. 2019;15(2):71-76. (In Russ.) https://doi.org/10.17650/1994-4098-2019-15-2-71-76